Development of a Laboratory Test for the Detection of a Fluorescent-labeled Urease Inhibitor Marker Attached to Helicobacter Pylori

Development of a Laboratory Test for the Detection of a Fluorescent-labeled Urease Inhibitor Marker Attached to Helicobacter Pylori Using Biopsies Taken During Gastroscopy in Patients in Which the Bacterium is Suspected

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04937426

Enrollment

200

Registered

2021-06-24

Start date

2021-07-31

Completion date

2022-07-31

Last updated

2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Pylori

Brief summary

The aim of this study is to compare the usual rapid urease test (RUT) to a new florescent-labeled urease inhibitor marker to diagnose Helicobacter Pylori.

Interventions

DIAGNOSTIC_TESTFluorescent-labeled Urease Inhibitor Marker to Detect Helicobacter Pylori

Diagnostic laboratory test for detection of helicobacter pylori

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients undergoing gastroendoscopy with suspected Helicobacter Pylori

Exclusion criteria

* Patients with active bleeding * Patients treated with anti-coagulation medication

Design outcomes

Primary

Measure	Time frame	Description
Efficacy of a Fluorescent-labeled Urease Inhibitor Marker to Detect Helicobacter Pylori Infection	Two years	Comparison of results of biopsies analyzed with a fluorescent-labeled urease inhibitor marker to detect Helicobacter Pylori infection and results will be compared to standard tests to detect Helicobacter Pylori

Countries

Israel

Contacts

Primary ContactNatalie Noam-Amar, MA

nataliea219@gmail.com052-3132408

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026